Document 0496 DOCN M9550496 TI HIV-1 envelope glycoprotein gp120 does not bind to galactosylceramide-expressing rat oligodendrocytes. DT 9505 AU Parmantier E; Monge M; Yagello M; Cabon F; Demerens C; Gluckman JC; Zalc B; Laboratoire de Neurobiologie Cellulaire, Moleculaire et; Clinique, INSERM U, 134, Paris, France. SO Virology. 1995 Feb 1;206(2):1084-91. Unique Identifier : AIDSLINE MED/95159420 AB It may be postulated that the encephalopathy induced by the human immunodeficiency virus HIV-1, in particular, the characteristic myelin pallor, may result from binding of the envelope glycoprotein gp120 to galactosylceramide and/or its metabolite sulfatide in the plasma membrane of oligodendrocytes, the myelin forming cells in the central nervous system. (1) gp120 has been reported to have a high affinity for these molecules in vitro. (2) The binding of antibodies to these molecules increases intracellular free calcium levels, which may be cytotoxic. (3) The binding of gp120 to the CD4 receptor in the immune system has the same effect. We have investigated the binding of gp120 to rat oligodendrocytes in vitro by indirect immunofluorescence and have monitored changes in intracellular free calcium with the calcium-sensitive dye INDO-1, in individual oligodendrocytes exposed to the glycoprotein. Antibodies against galatosylceramide and sulfatide bound to the cell membrane, but gp120 did not. The antibodies also increased intracellular free calcium levels in the oligodendrocytes, whereas gp120 did not. It, therefore, seems highly improbable that the demyelination observed during HIV encephalopathy is a direct cytotoxic effect of gp120 on oligodendrocytes. DE Animal Animals, Newborn Brain/CYTOLOGY/METABOLISM/VIROLOGY Calcium/METABOLISM Cell Differentiation Cell Membrane/METABOLISM Cells, Cultured Flow Cytometry Galactosylceramides/*BIOSYNTHESIS HIV Envelope Protein gp120/*METABOLISM HIV-1/*METABOLISM Oligodendroglia/CYTOLOGY/*METABOLISM/*VIROLOGY Protein Binding Rats Stem Cells/CYTOLOGY/METABOLISM/VIROLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).